218 related articles for article (PubMed ID: 10074982)
21. Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer.
Ness RB; Grisso JA; Cottreau C; Klapper J; Vergona R; Wheeler JE; Morgan M; Schlesselman JJ
Epidemiology; 2000 Mar; 11(2):111-7. PubMed ID: 11021606
[TBL] [Abstract][Full Text] [Related]
22. Use of talcum powder and endometrial cancer risk.
Neill AS; Nagle CM; Spurdle AB; Webb PM
Cancer Causes Control; 2012 Mar; 23(3):513-9. PubMed ID: 22245995
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for epithelial ovarian cancer in Beijing, China.
Chen Y; Wu PC; Lang JH; Ge WJ; Hartge P; Brinton LA
Int J Epidemiol; 1992 Feb; 21(1):23-9. PubMed ID: 1544753
[TBL] [Abstract][Full Text] [Related]
24. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
[TBL] [Abstract][Full Text] [Related]
25. Perineal use of talcum powder and endometrial cancer risk.
Karageorgi S; Gates MA; Hankinson SE; De Vivo I
Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1269-75. PubMed ID: 20406962
[TBL] [Abstract][Full Text] [Related]
26. Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study.
Rice MS; Murphy MA; Vitonis AF; Cramer DW; Titus LJ; Tworoger SS; Terry KL
Int J Cancer; 2013 Nov; 133(10):2415-21. PubMed ID: 23650079
[TBL] [Abstract][Full Text] [Related]
27. Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group.
Purdie D; Green A; Bain C; Siskind V; Ward B; Hacker N; Quinn M; Wright G; Russell P; Susil B
Int J Cancer; 1995 Sep; 62(6):678-84. PubMed ID: 7558414
[TBL] [Abstract][Full Text] [Related]
28. Cigarette smoking and the risk of epithelial ovarian cancer.
Franks AL; Lee NC; Kendrick JS; Rubin GL; Layde PM
Am J Epidemiol; 1987 Jul; 126(1):112-7. PubMed ID: 3591776
[TBL] [Abstract][Full Text] [Related]
29. Genital use of talc and risk of ovarian cancer: a meta-analysis.
Berge W; Mundt K; Luu H; Boffetta P
Eur J Cancer Prev; 2018 May; 27(3):248-257. PubMed ID: 28079603
[TBL] [Abstract][Full Text] [Related]
30. Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer.
Merritt MA; Green AC; Nagle CM; Webb PM; ;
Int J Cancer; 2008 Jan; 122(1):170-6. PubMed ID: 17721999
[TBL] [Abstract][Full Text] [Related]
31. Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of Women's Health Study Group.
Green A; Purdie D; Bain C; Siskind V; Russell P; Quinn M; Ward B
Int J Cancer; 1997 Jun; 71(6):948-51. PubMed ID: 9185694
[TBL] [Abstract][Full Text] [Related]
32. A review of perineal talc exposure and risk of ovarian cancer.
Harlow BL; Hartge PA
Regul Toxicol Pharmacol; 1995 Apr; 21(2):254-60. PubMed ID: 7644715
[TBL] [Abstract][Full Text] [Related]
33. Douching, Talc Use, and Risk of Ovarian Cancer.
Gonzalez NL; O'Brien KM; D'Aloisio AA; Sandler DP; Weinberg CR
Epidemiology; 2016 Nov; 27(6):797-802. PubMed ID: 27327020
[TBL] [Abstract][Full Text] [Related]
34. A meta-analytical approach examining the potential relationship between talc exposure and ovarian cancer.
Gross AJ; Berg PH
J Expo Anal Environ Epidemiol; 1995; 5(2):181-95. PubMed ID: 7492905
[TBL] [Abstract][Full Text] [Related]
35. Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study.
Hankinson SE; Hunter DJ; Colditz GA; Willett WC; Stampfer MJ; Rosner B; Hennekens CH; Speizer FE
JAMA; 1993 Dec; 270(23):2813-8. PubMed ID: 8133619
[TBL] [Abstract][Full Text] [Related]
36. Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls.
Terry KL; Karageorgi S; Shvetsov YB; Merritt MA; Lurie G; Thompson PJ; Carney ME; Weber RP; Akushevich L; Lo-Ciganic WH; Cushing-Haugen K; Sieh W; Moysich K; Doherty JA; Nagle CM; Berchuck A; Pearce CL; Pike M; Ness RB; Webb PM; ; ; Rossing MA; Schildkraut J; Risch H; Goodman MT;
Cancer Prev Res (Phila); 2013 Aug; 6(8):811-21. PubMed ID: 23761272
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for ovarian cancer in central Italy.
Greggi S; Parazzini F; Paratore MP; Chatenoud L; Legge F; Mancuso S; La Vecchia C
Gynecol Oncol; 2000 Oct; 79(1):50-4. PubMed ID: 11006030
[TBL] [Abstract][Full Text] [Related]
38. A case-control study of borderline ovarian tumors: the influence of perineal exposure to talc.
Harlow BL; Weiss NS
Am J Epidemiol; 1989 Aug; 130(2):390-4. PubMed ID: 2750733
[TBL] [Abstract][Full Text] [Related]
39. Talc, body powder, and ovarian cancer: A summary of the epidemiologic evidence.
Wentzensen N; O'Brien KM
Gynecol Oncol; 2021 Oct; 163(1):199-208. PubMed ID: 34366148
[TBL] [Abstract][Full Text] [Related]
40. Epidemiologic evidence for uterine growth factors in the pathogenesis of ovarian cancer.
Cramer DW; Xu H
Ann Epidemiol; 1995 Jul; 5(4):310-4. PubMed ID: 8520714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
